Georgetown Medical Center Study Shows Positive Results with NADH

Results of an FDA approved study conducted at Georgetown University Medical Center in Washington, D.C., indicate that NADH may be a valuable way to produce more energy.

In a double-blind, placebo controlled clinical trial, twenty-three patients were enrolled in 4, 8, and 12 week programs. Subjects were randomly assigned 10mg of NADH or placebo for a 4-week period. This was followed by a 4-week wash-out period where subjects gradually received a less potent dose of NADH until they were completely free of NADH. The wash-out period was then followed by another 4-week session in which subjects were crossed over to the alternate treatment program.

The results showed 6 of 23 (26%) of patients responded to the NADH, and showed a marked improvement in physical, psychological, and neurocognitive measures. Significantly, 8 of 11 (73%) study patients enrolled in a longer, open label follow-up study, showed significant improvement in energy levels. NADH was also shown to have a good safety record, with none of the subjects experiencing any significant adverse effects.

(Source: Forsyth LM, Preuss HG, MacDowell AL, et al. “Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome.” Annals of Allergy, Asthma and Immunology. 1999;82:185-191.)